Bitbio

bit.bio designs and manufactures human cells to advance drug discovery and biomedical research. Using our proprietary deterministic cell programming technology, opti-ox, we convert induced pluripotent stem cells (iPSCs) into any human cell type in one step. Our AI powered discovery platform identifies unique combinations of transcription factors that can program any desired cell type with exceptional purity and consistency at scale. Globally available, the ioCells™ portfolio features 55 products including: ioWild Type Cells, ioDisease Model Cells, CRISPR-Ready ioCells, and ioTracker Cells.